Profile data is unavailable for this security.
About the company
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). The Company is engaged in the development of its therapeutic asset and has established a pre-clinical development pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinson's disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS). Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-130.
- Revenue in CAD (TTM)6.20m
- Net income in CAD-22.81m
- Incorporated1990
- Employees21.00
- LocationAeterna Zentaris Inc315 Sigma DriveSUMMERVILLE 29486CanadaCAN
- Phone+1 (418) 652-8525
- Fax+1 (418) 948-9191
- Websitehttps://www.zentaris.com/
Mergers & acquisitions
| Acquired company | AEZS:TOR since announced | Transaction value |
|---|---|---|
| Ceapro Inc | -10.34% | 15.86m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeo Pharma Inc | 54.29m | -28.43m | 10.95m | 100.00 | -- | -- | -- | 0.2017 | -0.3255 | -0.3255 | 0.6249 | -0.4765 | 1.23 | 3.53 | 12.39 | 434,296.00 | -64.52 | -64.35 | -215.78 | -113.22 | 21.38 | 23.88 | -52.37 | -69.71 | 0.2974 | -1.33 | 3.51 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
| Medicure Inc | 21.69m | -921.00k | 11.17m | 25.00 | -- | 0.5613 | 8.95 | 0.5147 | -0.0893 | -0.0893 | 2.01 | 1.91 | 0.7486 | 2.52 | 4.36 | 867,760.00 | -3.19 | -13.42 | -4.43 | -18.28 | 64.48 | 61.87 | -4.25 | -27.38 | 1.55 | -19.84 | 0.0266 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
| CanadaBis Capital Inc | 20.91m | 3.27m | 11.83m | -- | 3.59 | 1.44 | 2.93 | 0.5659 | 0.0237 | 0.0237 | 0.1514 | 0.0592 | 0.9778 | 1.90 | 9.81 | -- | 15.27 | -20.55 | 27.30 | -54.86 | 52.50 | -- | 15.62 | -26.61 | 0.5509 | 7.88 | 0.4948 | -- | 90.44 | -- | 630.61 | -- | 238.08 | -- |
| Willow Biosciences Inc | 1.17m | -13.03m | 12.16m | 19.00 | -- | 3.44 | -- | 10.38 | -0.105 | -0.105 | 0.0094 | 0.0276 | 0.0944 | -- | 5.23 | 61,684.21 | -104.98 | -- | -122.40 | -- | -- | -- | -1,111.69 | -- | 2.18 | -- | 0.3856 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Delivra Health Brands Inc | 11.39m | -1.11m | 12.61m | -- | -- | 3.32 | 60.06 | 1.11 | -0.0044 | -0.0044 | 0.0423 | 0.012 | 1.05 | 2.17 | 5.95 | -- | -10.26 | -45.81 | -20.21 | -58.34 | 56.21 | 37.95 | -9.78 | -289.55 | 1.42 | -0.3789 | 0.346 | -- | 20.30 | 68.26 | 97.37 | -- | -56.72 | -- |
| AEterna Zentaris Inc. | 6.20m | -22.81m | 12.63m | 21.00 | -- | 0.5036 | -- | 2.04 | -4.70 | -4.70 | 1.28 | 5.16 | 0.0967 | 1.51 | 19.14 | -- | -35.58 | -26.24 | -40.64 | -30.34 | 95.06 | 83.68 | -368.01 | -300.31 | 8.00 | -- | 0.0151 | -- | -20.25 | -30.06 | 27.17 | -- | 16.12 | -- |
| Indiva Ltd | 37.57m | -4.92m | 13.80m | 142.00 | -- | -- | -- | 0.3674 | -0.0305 | -0.0305 | 0.2223 | -0.0018 | 0.993 | 6.02 | 8.32 | -- | -13.00 | -29.67 | -22.26 | -48.24 | 28.00 | 20.37 | -13.09 | -48.06 | 0.4537 | -0.5327 | 1.02 | -- | 9.21 | 264.60 | 55.01 | -- | -33.00 | -- |
| Tokens.com Corp | 1.11m | -8.21m | 14.03m | 4.00 | -- | 0.9053 | -- | 12.61 | -0.0657 | -0.0657 | 0.01 | 0.1270 | 0.0547 | -- | 5.17 | -- | -42.63 | -- | -50.94 | -- | 78.38 | -- | -779.43 | -- | -- | -- | 0.0112 | -- | -- | -- | -- | -- | -- | -- |
